Genelux Corporation (GNLX) vs Unicycive Therapeutics, Inc. (UNCY)
A side-by-side comparison of Genelux Corporation and Unicycive Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GNLX
Genelux Corporation
$2.54HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
UNCY
Unicycive Therapeutics, Inc.
$4.23HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — GNLX vs UNCY
growth of $100 · dividends reinvested · last 4yGNLX -57.7% (-19.4%/yr)UNCY -31.3% (-9.0%/yr)UNCY compounded faster over this window
GNLX UNCY
GNLX vs UNCY: by the numbers
- •GNLX is the larger company ($114M vs $113M market cap).
- •Both run net losses; UNCY's is the smaller (0.00% vs -422412.50% net margin).
Metrics side by side
Valuation
| Metric | GNLX | UNCY |
|---|---|---|
| P/S ratio | 14236.83 | N/A |
| P/B ratio | 7.07 | 2.12 |
Profitability
| Metric | GNLX | UNCY |
|---|---|---|
| Gross margin | -7075.00% | 0.00% |
| Operating margin | -415175.00% | 0.00% |
| Net margin | -422412.50% | 0.00% |
| ROE | -209.73% | -66.12% |
| ROIC | -192.18% | -62.15% |
Growth (annualized)
| Metric | GNLX | UNCY |
|---|---|---|
| Total return CAGR (5Y) | N/A | -32.14% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.